JOHANNESBURG Aug 26 South African pharmaceutical firm Adcock Ingram will dispose of its loss-making Indian unit, the company said in a statement on Wednesday.
Adcock Ingram bought unlisted Cosme Pharma for 822 million rand ($62.76 million) in 2013, but has had to write down its value by 278 million rand last year and a further 74.4 million rand this year, saying significant additional investment was needed to compete effectively in the Indian pharmaceutic...
Also read: South Korea to buy American gas, build new factories in US
Read more
